Home » EU Agency Reviews Roche’s Avastin in Breast Cancer
EU Agency Reviews Roche’s Avastin in Breast Cancer
September 24, 2010
European healthcare regulators are reviewing the benefits of Roche’s top-selling Avastin drug in breast cancer in the light of fresh clinical data, casting more uncertainty over its prospects.
CNBC
CNBC
Upcoming Events
-
21Oct